Market Place
Sourcing Support
Genmab Announces Financial Results for the First Half of 2024
08 Aug 2024 //
GLOBENEWSWIRE
Genmab Completes Acquisition of ProfoundBio
21 May 2024 //
GLOBENEWSWIRE
ProfoundBio to Present Data on Preclinical Programs at the AACR Meeting 2024
04 Apr 2024 //
PR NEWSWIRE
Genmab bulks ADC pipeline with $1.8-billion purchase of ProfoundBio
04 Apr 2024 //
GLOBENEWSWIRE
Genmab to Broaden & Strengthen Oncology Portfolio with Acq of ProfoundBio
03 Apr 2024 //
BUSINESSWIRE
Seattle biotech nabs $112M for four clinical-stage ADCs
13 Feb 2024 //
ENDPTS
ProoundBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of PRO1107
05 Feb 2024 //
PR NEWSWIRE
ProfoundBio to Participate in RBC Capital Markets and JP Morgan Conferences
05 Dec 2023 //
PR NEWSWIRE
ProfoundBio Presents Promising Data on ADC Programs
03 Nov 2023 //
BUSINESSWIRE
ProfoundBio Readies for Next Phase of Growth with Management Team Additions
02 Nov 2023 //
BUSINESSWIRE
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023
28 Sep 2023 //
PR NEWSWIRE
ProfoundBio Announces Further Advancement of Lead Programs - PRO1184
26 May 2023 //
PR NEWSWIRE
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184
03 Jan 2023 //
PR NEWSWIRE
ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184
03 Aug 2022 //
PRNEWSWIRE
ProfoundBio Announces Completion of $70M Series A+ Financing to Advance ADCs
02 Jun 2022 //
PRNEWSWIRE
ProfoundBio to Highlight Programs and Technology at AACR 2022
08 Mar 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.